3 not yet recruiting, 2 unknown. 2 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Not yet recruiting 1, Unknown 1 |
| Phase 3 | 1 | Not yet recruiting 1 |
Follow Chimeric Antigen Receptor T-cell Therapy: new trials by email Literature Review of Chimeric Antigen Receptor T-cell Therapy trials Research Report on Chimeric Antigen Receptor T-cell Therapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Symptom Monitoring and Management Intervention After CAR-T WAYPOINT - Chimeric Antigen Receptor T-cell Therapy, Hematologic Malignancy | Not applicable | Not yet recruiting | Massachusetts General Hospital | 65 | 2027-03-01 | 2026-10-23 |
| Immunoglobulin Replacement Therapy (IgRT) Versus Antibiotic Prophylaxis (PA) in Patients Treated by CD19-targeted Chimeric Antigen Receptor (CAR)T Cells for a B Cell Acute Lymphoblastic Leukemia or a B Cell Lymphoma Immunoglobulin, antibiotic prophylaxis - Chimeric Antigen Receptor T-cell Therapy, B Cell Acute Lymphoblastic Leukemia (B-ALL) | Phase 3 | Not yet recruiting | Assistance Publique - Hôpitaux de Paris | 228 | 2026-09-01 | 2026-08-10 |
| Study of the Association Between Fatigue Experienced by Patients and the Specific Side Effects of CART Cells, During the First Month After Administration for Non-Hodgkin's Lymphoma Fatigue assessment - Fatigue Symptom, Lymphoma Non-Hodgkin | Not yet recruiting | Assistance Publique - Hôpitaux de Paris | 100 | 2025-04-01 | 2025-03-21 | |
| Correlation Between Gut Microbiota and Clinical Response to CAR-T Treatment for Hematological Malignancies Hematological Malignancies, Chimeric Antigen Receptor T-cell Therapy | Unknown | The First Affiliated Hospital of Soochow University | 100 | 2023-09-03 | 2023-09-18 | |
| Early Integration of Palliative and Supportive Care in Cellular Therapy Early palliative and supportive care - Leukemia, Lymphoma | Not applicable | Unknown | Alberta Health Services, Calgary | 152 | 2022-04-08 | 2024-07-31 |
Hematologic Neoplasms (3) · Burkitt Lymphoma (1) · Fatigue (1) · Hematologic Diseases (1) · Leukemia (1) · Lymphoma (1) · Lymphoma, B-Cell (1) · Lymphoma, Non-Hodgkin (1) · Multiple Myeloma (1) · Neoplasms (1)
Hemic and Lymphatic Diseases (5) · Neoplasms (4) · Immune System Diseases (3) · Immunoproliferative Disorders (3) · Lymphatic Diseases (3) · Lymphoproliferative Disorders (3) · Neoplasms by Histologic Type (3) · Neoplasms by Site (3) · Hematologic Diseases (2) · Lymphoma (2) · Blood Protein Disorders (1) · Cardiovascular Diseases (1) · DNA Virus Infections (1) · Epstein-Barr Virus Infections (1) · Hemorrhagic Disorders (1)
Antibiotic Prophylaxis (1) · Immunoglobulins (1) · Palliative Care (1)
Assistance Publique - Hôpitaux de Paris (2) · Alberta Health Services, Calgary (1) · Massachusetts General Hospital (1) · The First Affiliated Hospital of Soochow University (1)
Canada (1) · China (1) · United States (1)
Reanne Booker, PhD(c) (1) · Xiaowen Tang, PhD (1)
R41CA314618 (1)